John D. Pak

Array ( [id] => 7474162 [patent_doc_number] => 20040097445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of translation initiation factor IF2 expression' [patent_app_type] => new [patent_app_number] => 10/298955 [patent_app_country] => US [patent_app_date] => 2002-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20467 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097445.pdf [firstpage_image] =>[orig_patent_app_number] => 10298955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860565 [patent_doc_number] => 20030091573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Methods and compositions for the diagnosis and treatment of hematological disorders using 16319' [patent_app_type] => new [patent_app_number] => 10/283023 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27555 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091573.pdf [firstpage_image] =>[orig_patent_app_number] => 10283023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843634 [patent_doc_number] => 20030148981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response' [patent_app_type] => new [patent_app_number] => 10/278429 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7881 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148981.pdf [firstpage_image] =>[orig_patent_app_number] => 10278429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669422 [patent_doc_number] => 20030114406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Hyaluronic acid microspheres for sustained gene transfer' [patent_app_type] => new [patent_app_number] => 10/277184 [patent_app_country] => US [patent_app_date] => 2002-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7301 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114406.pdf [firstpage_image] =>[orig_patent_app_number] => 10277184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166959 [patent_doc_number] => 20040077085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Antisense modulation of CDC14A expression' [patent_app_type] => new [patent_app_number] => 10/274387 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24921 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077085.pdf [firstpage_image] =>[orig_patent_app_number] => 10274387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792527 [patent_doc_number] => 20030087871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Antisense modulation of caspase 9 expression' [patent_app_type] => new [patent_app_number] => 10/271887 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26499 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087871.pdf [firstpage_image] =>[orig_patent_app_number] => 10271887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716436 [patent_doc_number] => 20030027784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Biologically tolerated low molecular weight polyethylenimines' [patent_app_type] => new [patent_app_number] => 10/265539 [patent_app_country] => US [patent_app_date] => 2002-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6773 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027784.pdf [firstpage_image] =>[orig_patent_app_number] => 10265539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668788 [patent_doc_number] => 20030113772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'DNA encoding human alpha 1 adrenergic receptors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/238667 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 24990 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113772.pdf [firstpage_image] =>[orig_patent_app_number] => 10238667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668787 [patent_doc_number] => 20030113771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'DNA encoding human alpha 1 adrenergic receptors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/238129 [patent_app_country] => US [patent_app_date] => 2002-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 24982 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113771.pdf [firstpage_image] =>[orig_patent_app_number] => 10238129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697283 [patent_doc_number] => 20030109477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => new [patent_app_number] => 10/224079 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14760 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109477.pdf [firstpage_image] =>[orig_patent_app_number] => 10224079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869909 [patent_doc_number] => 20030082598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Molecular interaction sites of 23S ribosomal RNA and methods of modulating the same' [patent_app_type] => new [patent_app_number] => 10/224836 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 28997 [patent_no_of_claims] => 128 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082598.pdf [firstpage_image] =>[orig_patent_app_number] => 10224836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403614 [patent_doc_number] => 20040023905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of LAR expression' [patent_app_type] => new [patent_app_number] => 10/210838 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31691 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023905.pdf [firstpage_image] =>[orig_patent_app_number] => 10210838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843581 [patent_doc_number] => 20030148928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Enzymatic nucleic acid peptide conjugates' [patent_app_type] => new [patent_app_number] => 10/201389 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22146 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148928.pdf [firstpage_image] =>[orig_patent_app_number] => 10201389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011388 [patent_doc_number] => 20050065104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Antisense modulation of acyl coenzyme a cholesterol acyltransferase-1 expression' [patent_app_type] => utility [patent_app_number] => 10/484437 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26472 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065104.pdf [firstpage_image] =>[orig_patent_app_number] => 10484437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870607 [patent_doc_number] => 20030083297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Antisense modulation of daxx expression' [patent_app_type] => new [patent_app_number] => 10/181846 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24427 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083297.pdf [firstpage_image] =>[orig_patent_app_number] => 10181846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364157 [patent_doc_number] => 20040005570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Antisense modulation of geranylgeranyl diphosphate synthase 1 expression' [patent_app_type] => new [patent_app_number] => 10/189268 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30291 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005570.pdf [firstpage_image] =>[orig_patent_app_number] => 10189268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364113 [patent_doc_number] => 20040005565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Antisense modulation of livin expression' [patent_app_type] => new [patent_app_number] => 10/188646 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30840 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005565.pdf [firstpage_image] =>[orig_patent_app_number] => 10188646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433150 [patent_doc_number] => 20040002152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Antisense modulation of P2X4 expression' [patent_app_type] => new [patent_app_number] => 10/187659 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30758 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002152.pdf [firstpage_image] =>[orig_patent_app_number] => 10187659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433145 [patent_doc_number] => 20040002151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Antisense modulation of selenophosphate synthetase 2 expression' [patent_app_type] => new [patent_app_number] => 10/186157 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29502 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002151.pdf [firstpage_image] =>[orig_patent_app_number] => 10186157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825289 [patent_doc_number] => 20030235911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Antisense modulation of PRL-3 expression' [patent_app_type] => new [patent_app_number] => 10/177554 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32328 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235911.pdf [firstpage_image] =>[orig_patent_app_number] => 10177554 [rel_patent_id] =>[rel_patent_doc_number] =>)